[Molecular basis of oral hypoglycemic sulfonylurea action].
D018528:ATP-Binding Cassette Transporters / Q000187:drug effects; D000284:Administration, Oral; D002462:Cell Membrane / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D015221:Potassium Channels / Q000187:drug effects; D024661:Potassium Channels, Inwardly Rectifying / Q000187:drug effects*; D011955:Receptors, Drug / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D064233:Sulfonylurea Receptors
C577507:ABCC8 protein, human; D018528:ATP-Binding Cassette Transporters; D007004:Hypoglycemic Agents; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D013453:Sulfonylurea Compounds; D064233:Sulfonylurea Receptors
Molekularne podstawy działania doustnych leków hipoglikemizujacych z grupy pochodnych sulfonylomocznika.